Phase 3 Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) - NCT04526665

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04526665